je.st
news
Shire PLC (SHP) Lifted to Outperform at BNP Paribas
2016-01-18 16:41:30| Biotech - Topix.net
The brokerage currently has a GBX 5,700 target price on the biopharmaceutical company's stock. BNP Paribas' price objective points to a potential upside of 36.20% from the company's previous close.
Tags: plc
lifted
shp
shire
Category:Biotechnology and Pharmaceuticals